Catalytic mechanism and novel receptor binding sites of human parainfluenza virus type 3 hemagglutinin-neuraminidase (hPIV3 HN)

Antiviral Research

Volumn 123, Issue , 2015, Pages 216-223

  Streltsov, Victor A ^a   Pilling, Pat ^a   Barrett, Susan ^a   McKimm Breschkin, Jennifer L ^a  

^a CSIRO   (Australia)

Author keywords

Catalytic mechanism; Hemagglutinin neuraminidase (HN); Human parainfluenza virus type 3 (hPIV3); Neuraminidase inhibitors; Receptor binding sites; structure

Indexed keywords

HN PROTEIN; ZANAMIVIR; PROTEIN BINDING; SIALIC ACID DERIVATIVE;

ARTICLE; BINDING SITE; CATALYSIS; CONTROLLED STUDY; COVALENT BOND; CRYSTAL STRUCTURE; CRYSTALLIZATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION ASSAY; HUMAN PARAINFLUENZA VIRUS 3; IC50; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RECEPTOR BINDING; VIRUS HEMAGGLUTINATION; VIRUS RELEASE; BIOTRANSFORMATION; CHEMISTRY; ENZYMOLOGY; HUMAN; METABOLISM; X RAY CRYSTALLOGRAPHY;

BINDING SITES; BIOTRANSFORMATION; CRYSTALLOGRAPHY, X-RAY; HN PROTEIN; HUMANS; PARAINFLUENZA VIRUS 3, HUMAN; PROTEIN BINDING; PROTEIN CONFORMATION; SIALIC ACIDS;

EID: 84947048285     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.08.014     Document Type: Article

References (44)

1. S. Barrett, P.G. Mohr, P.M. Schmidt, and J.L. McKimm-Breschkin Real time enzyme inhibition assays provide insights into differences in binding of neuraminidase inhibitors to wild type and mutant influenza viruses PLoS One 6 2011 e23627 10.1371/journal.pone.0023627
2. D.B. Berkowitz, K.R. Karukurichi, R. de la Salud-Bea, D.L. Nelson, and C.D. McCune Use of fluorinated functionality in enzyme inhibitor development: mechanistic and analytical advantages J. Fluor. Chem. 129 2008 731 742 10.1016/j.jfluchem.2008.05.016
3. T.J. Blick, T. Tiong, A. Sahasrabudhe, J.N. Varghese, P.M. Colman, G.J. Hart, R.C. Bethell, and J.L. McKimm-Breschkin Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en Virology 214 1995 475 484 10.1006/viro.1995.0058
4. T. Bousse, and T. Takimoto Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase protein J. Virol. 80 2006 9009 9016 10.1128/JVI.00969-06
5. S. Buchini, F.X. Gallat, I.R. Greig, J.H. Kim, S. Wakatsuki, L.M. Chavas, and S.G. Withers Tuning mechanism-based inactivators of neuraminidases: mechanistic and structural insights Angew. Chem. Int. Ed. Engl. 53 2014 3382 3386 10.1002/anie.201309675
6. W.P. Burmeister, B. Henrissat, C. Bosso, S. Cusack, and R.W. Ruigrok Influenza B virus neuraminidase can synthesize its own inhibitor Structure 1 1993 19 26 10.1016/0969-2126(93)90005-2
7. P.M. Colman, P.A. Hoyne, and M.C. Lawrence Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase J. Virol. 67 1993 2972 2980
8. A.R. Dinner, G.M. Blackburn, and M. Karplus Uracil-DNA glycosylase acts by substrate autocatalysis Nature 413 2001 752 755 10.1038/35099587
9. L. Dirr, I.M. El-Deeb, P. Guillon, C.J. Carroux, L.M. Chavas, and M. von Itzstein The catalytic mechanism of human parainfluenza virus type 3 haemagglutinin-neuraminidase revealed Angew. Chem. Int. Ed. Engl. 54 2015 2936 2940 10.1002/anie.201412243
10. P. Guillon, L. Dirr, I.M. El-Deeb, M. Winger, B. Bailly, T. Haselhorst, J.C. Dyason, and M. von Itzstein Structure-guided discovery of potent and dual-acting human parainfluenza virus haemagglutinin-neuraminidase inhibitors Nat. Commun. 5 2014 5268 10.1038/ncomms6268
11. J.H. Kim, R. Resende, T. Wennekes, H.M. Chen, N. Bance, S. Buchini, A.G. Watts, P. Pilling, V.A. Streltsov, M. Petric, R. Liggins, S. Barrett, J.L. McKimm-Breschkin, M. Niikura, and S.G. Withers Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity Science 340 2013 71 75 10.1126/science.1232552
12. M.C. Lawrence, N.A. Borg, V.A. Streltsov, P.A. Pilling, V.C. Epa, J.N. Varghese, J.L. McKimm-Breschkin, and P.M. Colman Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III J. Mol. Biol. 335 2004 1343 1357 10.1016/j.jmb.2003.11.032
13. A.J. McCoy, R.W. Grosse-Kunstleve, P.D. Adams, M.D. Winn, L.C. Storoni, and R.J. Read Phaser crystallographic software J. Appl. Crystallogr. 40 2007 658 674 10.1107/S0021889807021206
14. J.L. McKimm-Breschkin, and S. Barrett Neuraminidase mutations conferring resistance to laninamivir lead to faster drug binding and dissociation Antiviral Res. 114 2015 62 66 10.1016/j.antiviral.2014.12.004
15. J.L. McKimm-Breschkin, S. Barrett, Pudjiatmoko, M. Azhar, F.Y. Wong, P. Selleck, P.G. Mohr, J. McGrane, and M. Kim I222 neuraminidase mutations further reduce oseltamivir susceptibility of Indonesian Clade 2.1 highly pathogenic Avian Influenza A (H5N1) viruses PLoS One 8 2013 e66105 10.1371/journal.pone.0066105
16. J.L. McKimm-Breschkin, J. Williams, S. Barrett, K. Jachno, M. McDonald, P.G. Mohr, T. Saito, and M. Tashiro Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase J. Antimicrob. Chemother. 68 2013 2210 2221 10.1093/jac/dkt205
17. D.E. McRee XtalView/Xfit-A versatile program for manipulating atomic coordinates and electron density J. Struct. Biol. 125 1999 156 165 10.1006/jsbi.1999.4094
18. D.E. McRee, and J. Badger MIFit Manual. Version 3.0 for Windows and LINUX 2003-6 ©Rigaku New York
19. V.P. Mishin, M. Watanabe, G. Taylor, J. Devincenzo, M. Bose, A. Portner, and I.V. Alymova N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site J. Virol. 84 2010 3094 3100 10.1128/JVI.02331-09
20. P.G. Mohr, Y.M. Deng, and J.L. McKimm-Breschkin The neuraminidases of MDCK grown human influenza A (H3N2) viruses isolated since 1994 can demonstrate receptor binding Virol. J. 12 2015 67 10.1186/s12985-015-0295-3
21. G.N. Murshudov, A.A. Vagin, and E.J. Dodson Refinement of macromolecular structures by the maximum-likelihood method Acta Crystallogr. D53 1997 240 255 10.1107/S0907444996012255
22. S.L. Newstead, J.A. Potter, J.C. Wilson, G. Xu, C.-H. Chien, A.G. Watts, S.G. Withers, and G.L. Taylor The structure of Clostridium perfringens NanI sialidase and its catalytic intermediates J. Biol. Chem. 283 2008 9080 9088 10.1074/jbc.M710247200
23. A.J. Oakley, S. Barrett, T.S. Peat, J. Newman, V.A. Streltsov, L. Waddington, T. Saito, M. Tashiro, and J.L. McKimm-Breschkin Structural and functional basis of resistance to neuraminidase inhibitors of influenza B viruses J. Med. Chem. 53 2010 6421 6431 10.1021/jm100621s
24. Z. Otwinowski, and W. Minor Processing of X-ray diffraction data collected in oscillation mode. Methods in enzymology Macromol. Crystallogr. Part A 276 1997 307 326
25. D. Paul, S.E. O'Leary, K. Rajashankar, W. Bu, A. Toms, E.C. Settembre, J.M. Sanders, T.P. Begley, and S.E. Ealick Glycal formation in crystals of uridine phosphorylase Biochemistry (Mosc.) 49 2010 3499 3509 10.1021/bi902073b
26. M.S. Pegg, and M. von Itzstein Slow-binding inhibition of sialidase from influenza virus Biochem. Mol. Biol. Int. 32 1994 851 858
27. M. Porotto, M. Murrell, O. Greengard, and A. Moscona Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: an HN mutation diminishes the rate of F activation and fusion J. Virol. 77 2003 3647 3654 10.1128/JVI.77.6.3647-3654.2003
28. M. Porotto, M. Murrell, O. Greengard, M.C. Lawrence, J.L. McKimm-Breschkin, and A. Moscona Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites J. Virol. 78 2004 13911 13919 10.1128/JVI.78.24.13911-13919.2004
29. M. Porotto, M. Fornabaio, O. Greengard, M.T. Murrell, G.E. Kellogg, and A. Moscona Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site J. Virol. 80 2006 1204 1213 10.1128/JVI.80.3.1204-1213.2006
30. M. Porotto, M. Fornabaio, G.E. Kellogg, and A. Moscona A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism J. Virol. 81 2007 3216 3228 10.1128/JVI.02617-06
31. M. Porotto, Z. Salah, I. DeVito, A. Talekar, S.G. Palmer, R. Xu, I.A. Wilson, and A. Moscona The second receptor binding site of the globular head of the Newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion J. Virol. 86 2012 5730 5741 10.1128/JVI.06793-11
32. Schrodinger, L., 2010. The PyMOL Molecular Graphics System, Version 1.3r1.
33. S.S. Tai, O. Agafitei, Z. Gao, R. Liggins, M. Petric, S.G. Withers, and M. Niikura Difluorosialic acids, potent novel influenza virus neuraminidase inhibitors, induce fewer drug resistance-associated neuraminidase mutations than does oseltamivir Virus Res. 2015 10.1016/j.virusres.2015.07.015
34. P.J. Unrau, and D.P. Bartel An oxocarbenium-ion intermediate of a ribozyme reaction indicated by kinetic isotope effects Proc. Natl. Acad. Sci. U.S.A. 100 2003 15393 15397 10.1073/pnas.2433147100
35. J.N. Varghese, J.L. McKimm-Breschkin, J.B. Caldwell, A.A. Kortt, and P.M. Colman The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor Proteins 14 1992 327 332 10.1002/prot.340140302
36. J.N. Varghese, P.M. Colman, A. van Donkelaar, T.J. Blick, A. Sahasrabudhe, and J.L. McKimm-Breschkin Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases Proc. Natl. Acad. Sci. U.S.A. 94 1997 11808 11812
37. J.N. Varghese, P.W. Smith, S.L. Sollis, T.J. Blick, A. Sahasrabudhe, J.L. McKimm-Breschkin, and P.M. Colman Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase Structure 6 1998 735 746 10.1016/S0969-2126(98)00075-6
38. C.J. Vavricka, Y. Liu, H. Kiyota, N. Sriwilaijaroen, J. Qi, K. Tanaka, Y. Wu, Q. Li, Y. Li, J. Yan, Y. Suzuki, and G.F. Gao Influenza neuraminidase operates via a nucleophilic mechanism and can be targeted by covalent inhibitors Nat. Commun. 4 2013 1491 10.1038/ncomms2487
39. M. von Itzstein, W.Y. Wu, G.B. Kok, M.S. Pegg, J.C. Dyason, B. Jin, T. Van Phan, M.L. Smythe, H.F. White, S.W. Oliver, and et al. Rational design of potent sialidase-based inhibitors of influenza virus replication Nature 363 1993 418 423 10.1038/363418a0
40. A.G. Watts, P. Oppezzo, S.G. Withers, P.M. Alzari, and A. Buschiazzo Structural and kinetic analysis of two covalent sialosyl-enzyme intermediates on Trypanosoma rangeli sialidase J. Biol. Chem. 281 2006 4149 4155 10.1074/jbc.M510677200
41. R.M. Werner, and J.T. Stivers Kinetic isotope effect studies of the reaction catalyzed by uracil DNA glycosylase: evidence for an oxocarbenium ion-uracil anion intermediate Biochemistry (Mosc.) 39 2000 14054 14064 10.1021/bi0018178
42. M. Winger, and M. von Itzstein Exposing the flexibility of human parainfluenza virus hemagglutinin-neuraminidase J. Am. Chem. Soc. 134 2012 18447 18452 10.1021/ja3084658
43. M.D. Winn, C.C. Ballard, K.D. Cowtan, E.J. Dodson, P. Emsley, P.R. Evans, R.M. Keegan, E.B. Krissinel, A.G.W. Leslie, A. McCoy, S.J. McNicholas, G.N. Murshudov, N.S. Pannu, E.A. Potterton, H.R. Powell, R.J. Read, A. Vagin, and K.S. Wilson Overview of the CCP4 suite and current developments Acta Crystallogr. Sect. D 67 2011 235 242 10.1107/S0907444910045749
44. V. Zaitsev, M. von Itzstein, D. Groves, M. Kiefel, T. Takimoto, A. Portner, and G. Taylor Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion J. Virol. 78 2004 3733 3741 10.1128/JVI.78.7.3733-3741.2004